Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dominik Fischer, who completed his DPhil in our Department, received an extraordinary professorship at the Eberhard Karls University of Tübingen on Tuesday 7 July 2015.

In this clinical academic position, he will continue his work on retinal gene therapy at the Centre for Ophthalmology, Tübingen.

Dominik has been involved in pre-clinical and clinical gene therapy programmes in Professor Robert MacLaren’s group as MRC Clinical Research Training Fellow since 2012.

Professor Dominik Fischer is principal investigator of the first clinical retinal gene therapy trials in Germany with his team at the Universty Eye Hospital Tübingen.